Results 161 to 170 of about 114,424 (204)
Some of the next articles are maybe not open access.
NMDA Receptors as Voltage Sensors
2017The membrane potential is an essential parameter of a living cell. However, measurements of the membrane potential using conventional techniques are associated with a number of artifacts. Cell-attached recordings of the currents through NMDA receptor channels enable noninvasive measurements of the neuronal membrane potential.
openaire +4 more sources
Neuropharmacology, 2012
Cognitive dysfunction is core to schizophrenia, and remains poorly treated by existing therapies. A prominent hypothesis suggests that many symptoms arise from N-methyl-d-aspartate receptor (NMDAR) hypofunction. Subsequently, there has emerged a widespread use of many preclinical and clinical NMDAR antagonist models in the search for novel treatments ...
Gilmour +8 more
openaire +2 more sources
Cognitive dysfunction is core to schizophrenia, and remains poorly treated by existing therapies. A prominent hypothesis suggests that many symptoms arise from N-methyl-d-aspartate receptor (NMDAR) hypofunction. Subsequently, there has emerged a widespread use of many preclinical and clinical NMDAR antagonist models in the search for novel treatments ...
Gilmour +8 more
openaire +2 more sources
NMDA receptors and memory encoding
Neuropharmacology, 2013It is humbling to think that 30 years have passed since the paper by Collingridge, Kehl and McLennan showing that one of Jeff Watkins most interesting compounds, R-2-amino-5-phosphonopentanoate (d-AP5), blocked the induction of long-term potentiation in vitro at synapses from area CA3 of the hippocampus to CA1 without apparent effect on baseline ...
openaire +2 more sources
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
Cell, 2023S Momsen Reincke
exaly
Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond
Nature Reviews Drug Discovery, 2006Stuart A Lipton, Lipton Stuart A
exaly
Novel NMDA receptor modulators: an update
Expert Opinion on Therapeutic Patents, 2012Brooke M Katzman +2 more
exaly
Altered NMDA receptor expression in renal toxicity: Protection with a receptor antagonist
Kidney International, 2004Douglas M Silverstein
exaly

